Trending Medical and health breaking news FDA Approves Time-Saving Combo for R/r Multiple Myeloma

Trending Medical and also health and wellness splitting information FDA Authorizes Time-Saving Combination for R/r Numerous Myeloma

The US Food and Drug Administration (FDA) this week approved daratumumab + hyaluronidase-fihj (Darzalex Faspro) and carfilzomib (Kyprolis) plus dexamethasone (Kd) for patients with relapsed or refractory multiple myeloma who have had one to three prior lines of therapy. Using the newly approved combination in this setting is a time-saver for patients and clinics, observed…